Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$46,818,375
+$16,632,940 QoQ
Shares Held
186,053
+34.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#383
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banco Santander, S.A. holds $364,857,314 across 11 Drug Manufacturers - General names. ABBV ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
119,853 | $143,755,293 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
1,088,316 | $62,708,766 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
186,053 | $46,818,375 | |
| 4 | PFE |
Pfizer Inc
|
1,655,686 | $39,868,917 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
266,424 | $33,660,007 | |
| 6 | MRK |
Merck & Co., Inc.
|
117,047 | $15,040,538 | |
| 7 | JNJ |
Johnson & Johnson
|
39,557 | $10,046,290 | |
| 8 | AMGN |
Amgen Inc
|
18,674 | $6,762,228 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,818,375 | 186,053 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $30,185,435 | 138,790 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $33,271,797 | 145,616 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $35,510,593 | 153,367 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $28,261,942 | 152,257 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $18,024,166 | 86,026 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $13,050,998 | 73,444 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $12,744,765 | 64,537 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $17,541,178 | 102,269 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $31,498,018 | 172,971 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $44,236,340 | 285,451 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $39,787,094 | 266,920 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $34,351,028 | 254,962 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $27,641,450 | 173,442 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $28,317,141 | 175,219 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $25,139,277 | 187,313 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $31,136,202 | 203,292 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $33,646,739 | 207,555 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $31,277,805 | 231,003 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $23,671,423 | 219,444 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $20,328,815 | 180,476 | Shares | Defined | 2021-07-29 | |
| 2021-03-31 | $16,948,982 | 156,616 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $13,799,633 | 128,788 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $10,269,839 | 117,249 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $11,598,297 | 118,133 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,176,678 | 15,444 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||